© 2026 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 161 Farringdon Rd, London EC1R 3AL. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions | Cookies

Emerging Markets

Top section

Top section

◆ The threat of US corporate issuance to European borrowers ◆ The new funding environment for Middle East banks ◆ Reviving UK equity capital markets
Swiss investors retain appetite for credit as yields become more attractive
As war drags on, banks are boosting hoards of cash after deposit outflows

Data

More articles

More articles

More articles

  • Site visits for loan deals are often a bit of a bore. Unless the site was a brewery or distillery where we could sample the product, myself and my peers usually sent minions on the tour instead.
  • HSBC, Macquarie hire former Deutsche bankers – Citi’s Aus, NZ equities head steps down – CIMB rejigs top line-up – Hang Seng’s head of syndication leaves – Moody’s names Apac boss
  • China National Chemical Corp (ChemChina) is seeking lenders’ consent to amend terms of a $5.5bn dual-tranche loan sealed last year, as it undergoes a debt restructuring, according to bankers.
  • Shanghai Henlius Biotech has settled its Hong Kong SAR listing at the bottom of the price guidance, mopping up HK$3.21bn ($410m) from the first post-earnings season IPO in the city.
  • Budweiser Brewing Company Apac has revived its Hong Kong IPO two months after a headline-grabbing flop. But a smaller target size, a stamp of approval from a high-profile cornerstone investor and the off-loading of an unattractive chunk of its business all mean that the firm has a better chance of success this time around. Jonathan Breen reports.
  • Shandong Iron & Steel Group Co has made its annual return to the bond market, grabbing $500m thanks to support from foreign fund managers.